These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37591705)

  • 61. Novel mouse monoclonal antibodies against Bordetella pertussis pertactin antigen with versatile applications.
    Imani D; Bahadori T; Ghourchian S; Golsaz-Shirazi F; Douraghi M; Jeddi-Tehrani M; Amiri MM; Shokri F
    J Microbiol Methods; 2023 Aug; 211():106786. PubMed ID: 37454935
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries.
    Versteegen P; Barkoff AM; Valente Pinto M; van de Kasteele J; Knuutila A; Bibi S; de Rond L; Teräsjärvi J; Sanders K; de Zeeuw-Brouwer ML; Luoto R; Ten Hulscher H; Clutterbuck EA; Sanders EAM; Mertsola J; Berbers GAM; He Q; Kelly DF; Buisman AM;
    Front Immunol; 2022; 13():864674. PubMed ID: 35677044
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunoelectron microscopy of antigens of Bordetella pertussis using monoclonal antibodies to agglutinogens 2 and 3, filamentous haemagglutinin, pertussis toxin, pertactin and adenylate cyclase toxin.
    Blom J; Heron I; Hendley JO
    APMIS; 1994 Sep; 102(9):681-9. PubMed ID: 7946271
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Purification and partial characterization of filamentous haemagglutinin from Bordetella pertussis using monoclonal antibodies.
    Selmer JC; Larsen FS; Hertz JB; Parton R
    Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):279-84. PubMed ID: 6097092
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization and clinical study on the acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous hemagglutinin.
    Ginnaga A; Morokuma K; Aihara K; Sakou M; Imaizumi A; Suzuki Y; Sato H; Sato Y; Ueda K; Kuno-Sakai H
    Tokai J Exp Clin Med; 1988; 13 Suppl():59-69. PubMed ID: 2908528
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Simultaneous measurement of alpha-amylase and glucoamylase activities in sake rice koji by capillary electrophoresis of sodium dodecyl sulfate-protein complexes and activity measurement of glucoamylase by in-capillary enzyme reaction method.
    Watanabe T; Yamamoto A; Nagai S; Terabe S
    Electrophoresis; 1998 Oct; 19(13):2331-7. PubMed ID: 9788317
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Online mass spectrometry of CE (SDS)-separated proteins by two-dimensional capillary electrophoresis.
    Römer J; Montealegre C; Schlecht J; Kiessig S; Moritz B; Neusüß C
    Anal Bioanal Chem; 2019 Nov; 411(27):7197-7206. PubMed ID: 31616969
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
    Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M
    Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term immunogenicity of a single dose of acellular pertussis vaccine in paediatric health-care workers.
    Littmann M; Hülsse C; Riffelmann M; Wirsing von König CH
    Vaccine; 2008 May; 26(19):2344-9. PubMed ID: 18396360
    [TBL] [Abstract][Full Text] [Related]  

  • 70. International collaborative study: evaluation of proposed International Reference Reagent of pertussis antiserum (mouse) 97/642.
    Gaines Das R; Xing D; Rigsby P; Newland P; Corbel M
    Biologicals; 2001 Jun; 29(2):137-48. PubMed ID: 11580218
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
    Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Purification design and practice for pertactin, the third component of acellular pertussis vaccine, from Bordetella pertussis.
    Li Z; Zhang Y; Wang Q; Li Z; Liu Y; Zhang S; Zhang G; Ma G; Luo J; Su Z
    Vaccine; 2016 Jul; 34(34):4032-9. PubMed ID: 27302339
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pertussis immunization with acellular vaccines in Ghanaian children.
    Hori H; Afari A; Akanmori BD; Kamiya Y; Sakatoku H; Nkrumah FK; Kamiya H; Chazono M; Fukai K
    Ann Trop Paediatr; 1995 Jun; 15(2):141-6. PubMed ID: 7677415
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Subnanomolar detection limit for sodium dodecyl sulfate-capillary gel electrophoresis using a fluorogenic, noncovalent dye.
    Harvey MD; Bandilla D; Banks PR
    Electrophoresis; 1998 Sep; 19(12):2169-74. PubMed ID: 9761199
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Quantitative microcapillary electrophoresis immunoassay (mCE IA) for end-to-end analysis of pertactin within in-process samples and Quadracel® vaccine.
    Keizner D; Ghaffari S; Beheshti S; Newman E; Tulumello D; Kirkitadze M; Leach M
    J Pharm Biomed Anal; 2021 Sep; 204():114284. PubMed ID: 34332308
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of chemically cross-linked antigens for acellular pertussis vaccine.
    Watanabe M; Nagai M; Funaishi K; Endoh M
    Vaccine; 2000 Dec; 19(9-10):1199-203. PubMed ID: 11137257
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Granulocyte-macrophage colony-stimulating factor DNA prime-protein boost strategy to enhance efficacy of a recombinant pertussis DNA vaccine.
    Li QT; Zhu YZ; Chu JY; Dong K; He P; Feng CY; Hu BY; Zhang SM; Guo XK
    Acta Pharmacol Sin; 2006 Nov; 27(11):1487-94. PubMed ID: 17049126
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Randomized controlled trial of acellular diphtheria, pertussis and tetanus vaccines in southern Ghana.
    Afari EA; Kamiya Y; Nkrumah FK; Dunyo SK; Akpedonu P; Kamiya H; Fukai F
    Ann Trop Paediatr; 1996 Mar; 16(1):39-48. PubMed ID: 8787364
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Physicochemical characterisation of the pertussis vaccine.
    Ceccarini C; Contorni M; Costantino P; D'Ascenzi S; Gallo E; Maffei M; Mannucci D; Marsili I; Magagnoli C; Peppoloni S; Rappuoli R; Ravenscroft N; Ricci S
    Dev Biol (Basel); 2000; 103():175-88. PubMed ID: 11214235
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.